Evidence map›Paper›PMID 27812677›Full record

Observational studyArquivos brasileiros de cardiologia2016

Influence of Angiotensin-Converting-Enzyme Gene Polymorphism on Echocardiographic Data of Patients with Ischemic Heart Failure.

Gustavo Salgado Duque, Dayse Aparecida da Silva, Felipe Neves de Albuquerque, Roberta Siuffo Schneider, Alinne Gimenez, Roberto Pozzan, Ricardo Mourilhe Rocha, Denilson Campos de Albuquerque

Open access · diamondAbstract readObservational Study
In one paragraph

Observational study in Arquivos brasileiros de cardiologia, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Gustavo Salgado DuqueHospital Universitário Pedro Ernesto - Universidade Estadual do Rio de Janeiro (UERJ); RJ - Brazil.
Dayse Aparecida da SilvaLaboratório de Diagnósticos por DNA do Instituto de Biologia da Universidade do Estado do Rio de Janeiro, RJ - Brazil.
Felipe Neves de AlbuquerqueHospital Universitário Pedro Ernesto - Universidade Estadual do Rio de Janeiro (UERJ); RJ - Brazil.
Roberta Siuffo SchneiderHospital Universitário Pedro Ernesto - Universidade Estadual do Rio de Janeiro (UERJ); RJ - Brazil.
Alinne GimenezHospital Universitário Pedro Ernesto - Universidade Estadual do Rio de Janeiro (UERJ); RJ - Brazil.
Roberto PozzanHospital Universitário Pedro Ernesto - Universidade Estadual do Rio de Janeiro (UERJ); RJ - Brazil.
Ricardo Mourilhe RochaHospital Universitário Pedro Ernesto - Universidade Estadual do Rio de Janeiro (UERJ); RJ - Brazil.
Denilson Campos de AlbuquerqueHospital Universitário Pedro Ernesto - Universidade Estadual do Rio de Janeiro (UERJ); RJ - Brazil.
Universidade do Estado do Rio de Janeiro · BRHospital Universitário Pedro Ernesto · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background: Association between angiotensin-converting-enzyme (ACE) gene polymorphisms and different clinical and echocardiographic outcomes has been described in patients with heart failure (HF) and coronary artery disease. Studying the genetic profile of the local population with both diseases is necessary to assess the occurrence of that association.

objectives: To assess the frequency of ACE gene polymorphisms in patients with ischemic HF in a Rio de Janeiro population, as well as its association with echocardiographic findings.

methods: Genetic assessment of I/D ACE polymorphism in association with clinical, laboratory and echocardiographic analysis of 99 patients.

results: The allele frequency was: 53 I alleles, and 145 D alleles. Genotype frequencies were: 49.5% DD; 47.48% DI; 3.02% II. Drug treatment was optimized: 98% on beta-blockers, and 84.8% on ACE inhibitors or angiotensin-receptor blocker. Echocardiographic findings: difference between left ventricular diastolic diameters (ΔLVDD) during follow-up: 2.98±8.94 (DD) vs. 0.68±8.12 (DI) vs. -11.0±7.00 (II), p=0.018; worsening during follow-up of the LV systolic diameter (LVSD): 65.3% DD vs. 19.0% DI vs. 0.0% II, p=0.01; of the LV diastolic diameter (LVDD): 65.3% DD vs. 46.8% DI vs. 0.0% II, p=0.03; and of the LV ejection fraction (LVEF): 67.3% DD vs. 40.4% DI vs. 33.3% II, p=0.024. Correlated with D allele: ΔLVEF, ΔLVSD, ΔLVDD.

conclusions: More DD genotype patients had worsening of the LVEF, LVSD and LVDD, followed by DI genotype patients, while II genotype patients had the best outcome. The same pattern was observed for ΔLVDD. FUNDAMENTOS:: Associação entre polimorfismos genéticos da enzima conversora da angiotensina (ECA) e diferentes evoluções clínicas e ecocardiográficas foi descrita em pacientes com insuficiência cardíaca (IC) e coronariopatia. O estudo do perfil genético da população local com as duas doenças torna-se necessário para verificar a ocorrência dessa associação. OBJETIVOS:: Avaliar a frequência dos polimorfismos genéticos da ECA em pacientes com IC de etiologia isquêmica de uma população do Rio de Janeiro e sua associação com achados ecocardiográficos. MÉTODOS:: Avaliação genética do polimorfismo I/D da ECA associada a análise de dados clínicos, laboratoriais e ecocardiográficos de 99 pacientes. RESULTADOS:: Foram encontrados 53 alelos I, 145 alelos D, quanto aos genótipos da ECA: 49,5% DD, 47,48% DI, 3,02% II. O tratamento medicamentoso foi otimizado com 98% usando betabloqueadores e 84,8%, IECA ou bloqueador do receptor de angiotensina. Achados ecocardiográficos: diferença entre os diâmetros diastólicos do ventrículo esquerdo (ΔVED): 2,98±8,94 (DD) vs. 0,68±8,12 (DI) vs. -11,0±7,00 (II), p=0,018; piora evolutiva do diâmetro sistólico do VE (VES): 65,3 % DD vs. 19,0 % DI vs. 0,0 % II, p=0,01; do diâmetro diastólico do VE (VED): 65,3 % DD vs. 46,8 % DI vs. 0,0 % II, p=0,03; e da fração de ejeção do VE (FEVE): 67,3 % DD vs. 40,4 % DI vs. 33,3 % II, p=0,024. Correlação com alelo D: ΔFEVE, ΔVES, ΔVED. CONCLUSÕES:: Foram identificados mais pacientes com piora evolutiva da FEVE e dos diâmetros cavitários do VE no genótipo DD, seguido do DI, sendo o II o de melhor evolução. O mesmo padrão foi observado na ΔVED.

Indexed as

EchocardiographyPolymorphism, GeneticAdultAgedAged, 80 and overAngiotensin-Converting Enzyme InhibitorsCoronary Artery DiseaseFemaleGene FrequencyGenotypeHeart FailureHeart VentriclesHumansMaleMiddle AgedPeptidyl-Dipeptidase AAngiotensin-Converting Enzyme InhibitorsPeptidyl-Dipeptidase A

Identifiers

PMID27812677
PMCPMC5137389
OpenAlexW2530361945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.